Back to top
more

Doximity (DOCS)

(Delayed Data from NYSE)

$75.12 USD

75.12
1,364,908

+0.72 (0.97%)

Updated Sep 29, 2025 04:00 PM ET

After-Market: $75.14 +0.02 (0.03%) 6:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (63 out of 245)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Why Doximity (DOCS) Might be Well Poised for a Surge

by Zacks Equity Research

Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Equity Research

Doximity (DOCS) is a Great Momentum Stock: Should You Buy?

by Zacks Equity Research

Does Doximity (DOCS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Doximity (DOCS) Q3 Earnings and Revenues Top Estimates

by Zacks Equity Research

Doximity (DOCS) delivered earnings and revenue surprises of 36.36% and 10.60%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FXH

Zacks Equity Research

Revvity (RVTY) Surpasses Q4 Earnings Estimates

by Zacks Equity Research

Revvity (RVTY) delivered earnings and revenue surprises of 4.41% and 0.10%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Doximity (DOCS) Gains As Market Dips: What You Should Know

by Zacks Equity Research

Doximity (DOCS) closed the most recent trading day at $57.67, moving +0.95% from the previous trading session.

Zacks Equity Research

Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?

by Zacks Equity Research

Sector ETF report for FXH

Zacks Equity Research

The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC

by Zacks Equity Research

Doximity, Omnicell, Embecta, Cencora and EDOC are included in this Analyst Blog.

Urmimala Biswas headshot

4 MedTech Stocks Poised to Thrive Under Second Trump Presidency

by Urmimala Biswas

Four MedTech stocks that are set to benefit from Trump 2.0 are DOCS, OMCL, EMBC and COR.

Zacks Equity Research

Teladoc Partners With Amazon to Expand Chronic Care Program Reach

by Zacks Equity Research

TDOC collaborates with Amazon to enhance its reach for chronic condition management programs.

Zacks Equity Research

Doximity (DOCS) Stock Moves -0.16%: What You Should Know

by Zacks Equity Research

Doximity (DOCS) concluded the recent trading session at $55.48, signifying a -0.16% move from its prior day's close.

Zacks Equity Research

Compelling Reasons for Investors to Hold on to Centene Stock

by Zacks Equity Research

CNC remains well-poised for growth on the back of an expanding customer base, improved premiums, strategic acquisitions and commendable cash reserves.

Zacks Equity Research

The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta

by Zacks Equity Research

Doximity, BrightSpring Health Services and Embecta are part of the Zacks top Analyst Blog.

Nalak Das headshot

5 Momentum Stocks to Buy for January After a Tepid December

by Nalak Das

Five stocks have strong momentum for January. These are: DOCS, LUV, ALK, DBX, PARRA.

Zacks Equity Research

Ensign Group Bolsters Healthcare Portfolio With Nine New Facilities

by Zacks Equity Research

ENSG acquires operations of nine skilled nursing facilities, marking its debut in Alabama and strengthening its Tennessee footprint, to enhance care and grow its Skilled Services segment.

Urmimala Biswas headshot

3 Medical Services Stocks to Buy to Counter Labor Shortage Woes

by Urmimala Biswas

The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. DOCS, BTSG and EMBC are set to gain the most. However, healthcare staffing shortage is leading to an increase in labor wages.

Zacks Equity Research

Doximity (DOCS) Stock Moves -0.13%: What You Should Know

by Zacks Equity Research

The latest trading day saw Doximity (DOCS) settling at $53.39, representing a -0.13% change from its previous close.

Zacks Equity Research

Here's Why Encompass Health is a Smart Addition to Your Portfolio

by Zacks Equity Research

EHC is well-poised for growth on the back of robust demand for effective inpatient rehabilitation services, frequent expansion initiatives and solid cash reserves.

Zacks Equity Research

Should Janus Henderson Small Cap Growth Alpha ETF (JSML) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for JSML

Debasmita Chatterjee headshot

4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow

by Debasmita Chatterjee

Medical stocks are expected to reap the benefits of affordable health insurance plans, rising surgeries and widespread adoption of telehealth services in the days ahead. However, inflation and supply-chain woes may act as spoilsport.

Zacks Equity Research

Is Janus Henderson Small Cap Growth Alpha ETF (JSML) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for JSML

Zacks Equity Research

Doximity (DOCS) Ascends But Remains Behind Market: Some Facts to Note

by Zacks Equity Research

Doximity (DOCS) closed the most recent trading day at $58.18, moving +0.61% from the previous trading session.

Zacks Equity Research

Ensign Expands Footprint With Buyout of Eight Healthcare Facilities

by Zacks Equity Research

ENSG agrees to buy eight healthcare facilities from Providence Home and Community Care, expanding its footprint.

Debanjana Dey headshot

4 MedTech Stocks That Gained More Than 100% in 2024 With Room to Run

by Debanjana Dey

Here are some strong MedTech stocks - DOCS, CLOV, CLPT and HIMS - that are expected to provide promising gains.

Zacks Equity Research

Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how biote Corp. (BTMD) and Doximity (DOCS) have performed compared to their sector so far this year.